We only have this paper's title and publication details.
Read it at the sourceIn vitro analysis reveals reserpine enhances DNA damage caused by doxorubicin in HepG2 cells, suggesting a potential combination therapy approach.
No takes yet. Share an insight, caveat, or question.
Özdoğru et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: